HDFC Bank clarified that it does not intend to invest in IndusInd Bank. Instead, it would be investments by HDFC Bank group entities such as HDFC Mutual Fund, HDFC Life Insurance Company Limited and HDFC ERGO.
SMC Global said that Mphasis is attempting a constructive turnaround on the daily charts, supported by an emerging strong support near the demand zone where stock has built a triple bottom pattern.
Insurance companies like SBI Life Insurance, HDFC Life Insurance, Kotak Life Insurance, Aditya Birla Sun Life Insurance, Bajaj Life Insurance, TATA AIG General Insurance and Go Digit General Insurance also took part.
As far as FY26 earnings revisions go, the top upgrades include HDFC Bank (up 4.2 per cent), Shriram Finance (up 4.5 per cent), UltraTech Cement (up 3.2 per cent), and Dr Reddy’s Laboratories (up 2.9 per cent).
Stocks including Rubicon Research, Canara Robeco AMC, BEL, Axis Bank, IEX, HDFC Life, Hero Moto, Adani Green and more will be in the spotlight on Thursday, October 16.
Religare has assigned a 'Buy' rating on RIL, with a target price of Rs 1,600, implying a potential upside of 16.4 per cent.
Top Indian mutual funds such as HDFC Mutual Fund and ICICI Prudential MF were among the investors, joined by Life Insurance Corporation of India (LIC) and international players including Goldman Sachs and Morgan Stanley.
Trading volumes for HDFC Life and its competitors rose as the market responded to JPMorgan's bullish stance.
Stocks including NTPC, Zydus Lifesciences, Indian Hotels, Bharat Forge, Rail Vikas Nigam, NHPC, Varun Beverages, HDFC Life, Biocon and more will be in the spotlight on Friday, September 05.
Shares of Insurance company were off to a strong start on Thursday after the GST rationalization announcement, but the momentum could not sustain.
Tata AIA, Axis Max Life and HDFC Life led in total APE performance, while IPRU Life and BALIC reported declines, indicating a mixed competitive landscape.





